Renaissance Technologies
LUNG icon

Renaissance Technologies’s Pulmonx LUNG Stock Holding History

Renaissance Technologies’s Portfolio LUNG Stock Details LUNG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$553K Buy
425,110
+104,810
+33% +$144K ﹤0.01% 2566
2026
Q1 		$413K Buy
320,300
+28,300
+10% +$46.8K ﹤0.01% 2678
2025
Q4 		$645K Sell
292,000
-40,810
-12% -$76.7K ﹤0.01% 2476
2025
Q3 		$539K Buy
332,810
+81,500
+32% +$170K ﹤0.01% 2757
2025
Q2 		$651K Buy
251,310
+86,010
+52% +$339K ﹤0.01% 2707
2025
Q1 		$1.11M Sell
165,300
-55,210
-25% -$391K ﹤0.01% 2353
2024
Q4 		$1.5M Buy
220,510
+61,500
+39% +$405K ﹤0.01% 2236
2024
Q3 		$1.32M Sell
159,010
-142,400
-47% -$1.03M ﹤0.01% 2284
2024
Q2 		$1.91M Buy
301,410
+34,800
+13% +$268K ﹤0.01% 1912
2024
Q1 		$2.47M Buy
266,610
+71,447
+37% +$838K ﹤0.01% 1892
2023
Q4 		$2.49M Buy
195,163
+117,153
+150% +$1.22M ﹤0.01% 1816
2023
Q3 		$806K Sell
78,010
-14,390
-16% -$167K ﹤0.01% 2445
2023
Q2 		$1.21M Sell
92,400
-102,445
-53% -$1.25M ﹤0.01% 2347
2023
Q1 		$2.18M Buy
194,845
+176,803
+980% +$1.75M ﹤0.01% 1978
2022
Q4 		$152K Buy
+18,042
New +$172K ﹤0.01% 3505
2022
Q2 		– Sell
-81,600
Closed -$2.02M – 4435
2022
Q1 		$2.02M Sell
81,600
-71,700
-47% -$1.85M ﹤0.01% 2228
2021
Q4 		$4.92M Buy
153,300
+63,200
+70% +$2.31M 0.01% 1545
2021
Q3 		$3.24M Buy
90,100
+61,800
+218% +$2.43M ﹤0.01% 1725
2021
Q2 		$1.25M Buy
+28,300
New +$1.23M ﹤0.01% 2560

Other funds holding LUNG

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ECM
ExodusPoint Capital Management New York $15.5B AUM 38.81% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $417M AUM 22.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Renaissance Technologies's LUNG Position: Q2 2026 in Review

Renaissance Technologies increased its Pulmonx (LUNG) stake by 33% in Q2 2026, buying an estimated $144K and bringing the position to 425,110 shares worth $553K. The position accounts for ﹤0.01% of the portfolio, ranked #2566.

Renaissance Technologies first reported a position in LUNG in Q2 2021 and has held it in 19 quarters since. The position peaked at $4.92M in Q4 2021. 108 funds tracked by Wall St. Rank hold LUNG as of Q2 2026.

  • Renaissance Technologies held 425,110 shares of Pulmonx worth $553K as of Q2 2026.
  • Renaissance Technologies bought 104,810 Pulmonx shares in Q2 2026, an estimated $144K.
  • Pulmonx made up ﹤0.01% of Renaissance Technologies's portfolio in Q2 2026, its #2566 holding.
  • Renaissance Technologies first reported a position in Pulmonx in Q2 2021 and has held it in 19 quarters since.
  • Renaissance Technologies's Pulmonx position peaked at $4.92M in Q4 2021.
  • 108 funds tracked by Wall St. Rank held Pulmonx as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.